We studied hepatitis B virus (HBV) transmission among 7416 Thai children from 148 schools in Kamphaeng Phet province, a rural part of northern Thailand. Their age ranged from 2 to 16 years (median 9 years). Between May 1991 and June 1992, 61 of 2593 (2.4%) in the cohort of susceptible children acquired anti-HBc immunoglobulin. Forty-seven of the 148 schools had children who acquired anti-HBc. School seroconversion rates to anti-HBc varied from 0% to 23%. There was no correlation between percent of carriers in schools and percent of anti-HBc acquisition. Of the 61 children who acquired anti-HBc, eight (13%) became HBsAg carriers but only two were symptomatic, for a clinical to subclinical infection ration of 1 : 30. One of the two symptomatic children became an HBsAg carrier. Three (38%) of the eight who were persistently antigenemic developed antibody to hepatitis B virus e antigen. Males were 2.5 times (95% CI 1.4-4.3) more likely to acquire anti-HBc than females. Risk factors for acquisition of HBc in Thailand over a 9-month period were examined in a subset of 2412 susceptible children and later in a case-control study of 22 children who acquired anti-HBc and 59 age and sex-matched controls. Risks for acquiring anti-HBc were male gender and a history of bleeding gums. In comparing this study to an earlier pilot study among 9848 children from the same area in Thailand, the yearly antibody acquisition rate to anti-HBc among Thai children dropped from 5.7% in 1989 to 2.4% in 1992. A random sample of children in the pilot study showed that 16% were HBsAg positive and 27% had anti-HBc at the beginning of the study. 34% had markers for either anti-HBc or HBsAg. 12% were repeatedly positive for HBsAg a year later.
Introduction
Hepatitis B virus (HBV) is a major cause of acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma (Okoth 1996) . Almost 300 million people are chronic carriers of HBV and provide a source of virus for transmission (Gust & Ruff 1993) . Infection in children is usually subclinical, serving as a source of infection for other young children (Robson et al. 1994) . 75% of the world's HBsAg carriers live in Asia. 25% to 50% of carriers go on to develop primary hepatocellular carcinoma (Payne et al. 1996) . Although most paediatric HBV infections are asymptomatic, many become chronic (Fishman et al. 1996) . The age of infection is associated with outcome. The younger the child when infected, the greater the chance of becoming a carrier (Chang 1996) .
Thailand is highly endemic for HBV with a HBsAg carrier rate of 10% (Grossman et al. 1975) . Transmission of HBV in South-east Asia is thought to be mostly vertical, from carrier mother to child at birth (Katelaris et al. 1995) , but horizontal transmission, close contact in a family or socially, is also important (Nemba et al. 1993) . Horizontal transmission in endemic areas is common; however, repetitive intimate household contact seems necessary for transmission to occur. Chronic HBV carriers are a potential risk to other family members (Romero & Lavine 1994) .
HBV has been isolated from or detected in a wide variety of body fluids (Robson et al. 1994 ) with several possible routes of transmission suggested. HBV infection is more prevalent in individuals living under poor socioeconomic conditions (Robson et al. 1994) . Some studies on risk factors for HBV infection have found a correlation with person-toperson transmission, while many other studies have shown weak evidence (Szmuness et al. 1973; Barrett et al. 1977; Oleske et al. 1980; Leichtner et al. 1981; Mazzur et al. 1981 ; Schreeder et al. 1983; Whittle et al. 1983; Botha et al. 1984; Kashiwagi et al. 1984) .
There has been little research on hepatitis transmission among school children in Thailand. Pongpipat et al. (1985) studied perinatal transmission of HBV in Thailand, and the prevalence of HBeAg and anti-HBe among HBsAg carrier Thai children (Pongpipat et al. 1981) . Their studies suggested healthy HBsAg carrier children played a major role in the transmission of HBV in Thailand. Grossman et al. (1975) looked at the prevalence and incidence of HBV among all ages in a low-income population of Bangkok, and reported that close person-to-person contact with carriers was an important mode of transmission.
In this paper we report the prevalence and incidence of HBV antibody and antigen among schoolchildren in a rural province of Thailand from 1989 to 1992. A reduction in HBV transmission was documented. Risk factors for HBV transmission among school children were also evaluated.
Materials and methods
We conducted a pilot study to determine hepatitis A and B virus rates of infection among rural Thai school children from Kamphaeng Phet province. A cohort of 9848 study participants from 28 scattered communities in the province was enrolled in February 1989. From March to December 1989, all illnesses resulting in school absence of three or more days were evaluated. Acute hepatitis B was defined by compatible symptoms, elevated serum alanine aminotransferase level, and IgM to HBc (Corzyme-M, Abbott Laboratories, Abbott Park, IL, USA). Antibody to HBc (Corzyme, Abbott Laboratories) and HBs antigen (HBsAg; Auszyme, Abbott Laboratories) prevalence was determined for a random sample of 1903 children at the time of enrolment and one year after study entry. Parents or guardians of the study volunteers provided written informed consent.
We followed up on this pilot study by taking a 20% random sample (n ϭ 7416) of primary school children from the same province concurrently enrolled in a hepatitis A vaccine efficacy trial (Innis et al. 1994) . Primary school education is compulsory in Thailand, thus this cohort should be representative of all similar aged children in the province. In the hepatitis A study, half of the children were given hepatitis B vaccine (Engerix-B, SmithKline Beecham Biologicals, Rixensart, Belgium) as a control vaccine while the other half received the test vaccine (Havrix, SmithKline Beecham Biologicals). Parents or guardians of the study volunteers provided written informed consent. The 20% random sample provided periodic (approximately every 6 months) serum specimens which were tested for hepatitis antibodies and antigens. Antibody to HBc prevalence was determined from the entire random sample at the beginning of the study prior to vaccination. HBsAg was tested only on those who were antiHBc positive. Incidence between May 1991 and June 1992 was determined from a cohort (n ϭ 2593) comprised of children in the random sample who received hepatitis A vaccine, were susceptible to becoming infected with HBV, and were still available for venipuncture in June 1992. All illnesses of two or more days reported to 92 primary health care clinics were evaluated. Hepatitis B illness was defined as in the pilot study. Seroconversion (HBV infection) was defined as serum negative for antibody to anti-HBc in May 1991 and positive thereafter until June 1992. All serologies were performed according to the manufacturer's instructions. HBsAg carriers were defined as repeatedly positive in two or more samples at least 6 months apart. Serial serum specimens from HBsAg carriers were tested for HBe antigen and antibody to HBe (Abbott Laboratories).
Risk factors for HBV infection were evaluated in two separate approaches over a 9-month period from September 1991 to June 1992 in 2412 of the 2593 children identified as still susceptible to HBV in September 1991. In June 1992 a Thai language questionnaire was administered which asked about exposure such as transfusions, surgery, sutures, dental work, haircuts with razors, immunization injections (other than study vaccines), injections (curative) other than vaccines, and exposure to bedbugs. The questionnaire covered only the previous 9 months. Statistical analyses were performed using SPSS/PC (SPSS Inc, Chicago, Illinois, USA). Univariate analysis was used to find factors associated with acquiring HBV infection. Relative risk and 95% confidence intervals were determined. We attempted to fit a model using logistic regression analysis and included those variables from univariate analysis with a P-value Յ 0.20.
The second approach took those children from the subset of 2412 who acquired anti-HBc during the 9-month observational period from September 1991 to June 1992 as cases in a nested case-control study. Three times the number of cases were chosen as controls from the same population of susceptibles who did not seroconvert during the same time period matched by age, sex, grade, and school. A second questionnaire was given to this group of children that asked about other possible exposures (such as sharing toothbrushes, cups, towels, food and water, presence of mosquitoes, and vaccines given). EpiInfo 6 (Version 6.04b, January 1997) was used to perform a stratified Mantel-Haenszel analysis, each stratum consisting of a single case and its matched controls.
Results
The 9848 volunteers from the 1989 pilot study ranged in age from 4 to 15 years, the median age was 9.0 years. The male to female ratio was 1 : 1 (4932 : 4916). At entry in February 1989, 508 (27%) of the random sample of 1903 had antibody to HBc and 301 (16%) had a repeatedly positive test for HBsAg (see Table 1 ). Of the random sample, 355 were lost to follow up in the one year period. 180 children (median age 9 years, M : F ratio 99 : 81) were HBsAg positive in February 1989 and still positive 1 year later for a prevalence of HBsAg chronic infection of 11.6% (180/1548). Of the 301 children who carried HBsAg in February 1989, 180 (60%) still carried it one year later. One year after study entry, 63 (5.7%, 95% CI ϭ 4.3, 7.1) of the 1114 susceptible children seroconverted to HBc, indicating they had sustained an HBV infection. Of these 63, eight were symptomatic, for an annual incidence of symptomatic hepatitis B of 97/100 000 (8 : 9848 in a 10-month period). Those who seroconverted were similar to those who remained susceptible in terms of age (6-12 years, median age 9) and gender (male to female ratio 1.0 : 1.1 (30 : 33)). Community seroconversion rates varied from 0 to 43%.
At the beginning of the Havrix vaccine study in 1991, 7416 children made up the 20% random sample. Ages ranged from 2 to 16 years, median age 9.0 years. The male to female ratio was 1. 00 : 0.96 (3808 : 3608) . At the beginning of data collection in May 1991, following administration of HBV vaccine to half of the 20% random sample, a cohort of 2593 of the children was susceptible to HBV infection and was available for venipuncture in June 1992 (Table 2) . Between May 1991 and June 1992, of the 2593 participants, 61 (2.4%, 95% CI ϭ 1.8, 3.0, median age 8.5 years) of the susceptible children acquired anti-HBc. The seroconversion rate in the 2-4-year-olds was 7.1%, in the 5-7-year-olds, 1.8%, in the 8-10-year-olds, 2.2%, and in the 11-13-year-olds, 4.0%. Males were 2.5 times (95% CI ϭ 1.4, 4.3) more likely to acquire antibody than females. Forty-seven of the 148 communities (32%) had children who acquired antibody. Community seroconversion rates varied from 0% to 23%.
Of the 61 children who acquired antibody between May 1991 and June 1992, eight (13.1%) continued as HBsAg carriers. Only two were symptomatic, so the annual incidence of symptomatic hepatitis B was 77/100 000 (2/2593). The ratio of clinical to subclinical infection was 1 : 30. The two children with clinically apparent infections were aged 5 and 7 years and the median age of children with subclinical infection was 9 years. One of the two symptomatic patients became an HBsAg carrier. Once infected, the proportion that became carriers was highest in the 2-4-year-old age group. Once infected, girls (5/18) had a 4.0 (95% CI ϭ 1.1, 15.0) times greater risk of becoming a carrier of HBsAg than boys (3/43). The baseline prevalence of chronic infection in schools at the beginning of the study varied from 0% to 19.4%. There was no correlation (correlation coefficient ϭ 0.1585) between the prevalence of carriers in schools and the rate of seroconversion in these schools. Three (38%) of the eight who were persistently antigenemic developed antibody to HBeAg. Sixty-two percent (38/61) of the children who acquired anti-HBc also developed antibody to HBeAg. Risk factors for the acquisition of anti-HBc were evaluated in June of 1992 among the 2412 study volunteers who received the hepatitis A vaccine, underwent regular venipuncture, and were still susceptible to hepatitis B infection (were anti-HBc and HBsAg negative) in September 1991. The age range was 4-15 years, median age 9 years. Twentyeight children in this group who answered the questionnaire, age range 4-13 years, median age 9.5 years, acquired antiHBc during the 9-month period. The male : female ratio for the entire questionnaire subset was 1 : 1.04 (1178 : 1234), while for the children who acquired anti-HBc the ratio was 1 : 0.4 (20 : 8). The cases did not cluster by school, by primary health care clinic, or by district. The relative risk (RR) of infection with hepatitis B for those attending a rural school vs. schools in towns approached statistical significance at 2.1 (95% CI ϭ 0.96-4.52). Only one factor, male gender, was associated with acquiring hepatitis B infection (see Table 3 ). The RR for male gender was 2.62 (95% CI ϭ 1.16, 5.92). Three variables with P-values Յ 0.20 were entered into the Logistic Regression model: gender, immunization injection and curative injection, but none were good predictors as none of the seroconversions were correctly classified.
For the nested case-control study, 22 cases and 59 controls were included, 55 males and 26 females. Fifteen of the cases were male and seven were female. A significant association was found between seroconversion to hepatitis B and bleeding gums (P ϭ 0.02, Table 4 ). A stepwise logistic regression model was fitted with bleeding gums as the sole independent variable and accounted for just 7.7% of the variation in the outcome (P ϭ 0.04). 
Discussion
We found remarkably high HBV infection rates, independent of age, among primary school children in rural Thailand in two different cohorts formed in 1989 and 1991. These cohorts were assembled to prepare for a hepatitis A vaccine study. Nevertheless, we seized the opportunity to study hepatitis B, a far more serious form of viral liver disease. HBV horizontal transmission resulted from non-sexual exposure through chronically infected persons capable of sustaining transmission. Rates varied by community; astoundingly, in each cohort were represented communities in which a major fraction of susceptible children were infected in the course of one year of observation. Ten years ago hepatitis B was a major public health problem in the study province.
In the first cohort, the age-specific prevalence of antibody to HBc indicating past infection was consistent with an annual infection incidence of several percent. The incidence observed over the succeeding year was 5.7%, a higher than expected rate. Other evidence of a possible increase in HBV transmission just before the cohort's formation was the unexpectedly high 15.8% prevalence of HBsAg. A year later, only 60% of those initially detected to have HBsAg were still antigenemic, suggesting the other 40% had sustained acute rather than chronic infections. The cohort was comprised of children from 28 communities; one community was remarkable in that 43% of its susceptible children in the cohort acquired HBV infection while under observation. We wondered if re-use of contaminated injection devices fuelled the high transmission rate and determined to evaluate risk factors for HBV transmission in a second cohort study.
In the second cohort, we found an annual incidence of HBV infection of 2.4%, approximately half the rate observed earlier. Incidence was similar across groups from ages 2-4 to 11-13, suggesting that horizontal transmission was nonsexual yet posed a universal risk. Thus it is important to give hepatitis B vaccine at an early age especially when the source of horizontal transmission cannot be identified. The 1992 World Health Assembly recommended that all countries have national HBV control programs by 1997 (Gust & Ruff 1993) and, in places where prevalence of HBsAg is over 8%, national infant vaccination by 1995. The policy since 1992 at the provincial hospital in Thailand, where this study took place, has been to vaccinate all newborns. The data presented here offer an opportunity to compare infection incidence today with that of 1990 and 1992 to see how effective this program has been.
Vaccination programs in other Asian countries have been successful. Voluntary HBV vaccination was introduced in Singapore in 1983 and compulsory vaccination of babies born to Hepatitis HBeAg positive mothers in 1985. Between 1989 and 1995 the number of cases of acute hepatitis B in Singapore fell by 60% (Guan 1996) . A nationwide HBV vaccination program was begun in Taiwan in 1984. Ten years later the HBsAg carrier rate in Taiwan was reduced to less than 1% in children under 10 years, with the ultimate goal of preventing HBV-related chronic liver disease and hepatocellular carcinoma in sight (Chang 1996) .
The proportion of children who became carriers was highest in the youngest age group (2-4 years). Alter and Mast (1994) note that in the US, which has a lower HBV incidence than Thailand, infections in children under 5 years account for 20% to 30% of all chronic HBV infections. The risk of developing the carrier state is highest among the younger age groups, as shown by McMahon et al. (1985) and Mahoney et al. (1995) . Romero and Lavine (1994) demonstrated that children infected between 2 and 5 years have a 50% chance of developing chronic HBV infection. Our pilot cohort study found that 11.6% were HBsAg chronic carriers. This appears to be higher than the 7.3% prevalence in a similar age group in the Khao Yai study in Thailand in 1976 (Snitbhan et al. 1976) , and the 8.25% prevalence in another similar age group in Bangkok (low-income housing) in 1971 (Grossman et al. 1975) . On the other hand, the two earlier studies used an earlier generation, less sensitive test for HBsAg. Whether incident infections were contributing to the pool of chronically infected children to sustain transmission was not determined.
In the second cohort study, we followed those with incident infection to determine who remained persistently antigenemic. Thirteen percent (8/61) of the children who acquired anti-HBc were identified as HBsAg carriers, although they did not necessarily continue as carriers over an additional 1.5 years of follow-up. Thirty-eight percent (3/8) of these carriers developed antibody to HBeAg. Bortolloti et al. (1990) showed in a study of Italian children that following acquisition of antibody to HBe, HBV replication ended. Hoofnagle and Di Bisceglie (1991) also noted that most patients with anti-HBeAg have resolving or little liver disease, although exceptions have occurred in children. Once infected, girls had a greater risk of becoming a carrier of HBsAg than boys in our prospective study. If they continue as carriers, girls remain potentially infective to their offspring.
Almost 40% of patients with acute hepatitis B have no recognized risk factor (Becherer 1995) . How HBV is being transmitted in Thailand to sexually immature schoolchildren remains an important and largely unanswered question showing the importance of universal immunization. Our study showed that boys were more likely to become infected in this province than girls and that bleeding gums seemed to be a risk factor. Bleeding gums can be a sign of gingival disease; friable gingival mucosa could provide a portal of entry for the virus, facilitating transmission when a child introduces a material or object contaminated by saliva or blood from a carrier into his or her mouth. Since we found no correlation between prevalence of carriers in school with seroconversion in that school, and since the presence of carriers is an important source of transmission, we conclude that infection risk in our study arose from outside the classroom setting. Infection risk arose outside of attendance at the primary health care clinics, since we found no association with injections, most of which are administered at these clinics.
Why did the HBV infection incidence decline by half from the first to second cohort? One conjecture from the pilot study was that the hepatitis B outbreaks apparent in several communities might have been due to re-use of contaminated needles. In 1991-1992 the case control study was carried out to determine if the use of needles was a risk factor for seroconversion to hepatitis B; we found no evidence that injections conferred risk, nor did we compile data that injections were excessively frequent. On the other hand, in the interval between the two cohorts, a province-wide hepatitis A vaccine trial was begun in Kamphaeng Phet, making sterile, disposable needles and syringes freely available to all 92 primary health care clinics in the project. It may be that these newly available quantities of disposable syringes helped to change the risk factors for HBV seroconversion. Other reasons for the drop in incidence since the pilot study could include improvement of medical facilities, better training of health personnel, and/or a greater awareness of blood transmitted factors. It would be interesting to investigate the carrier status of family members of schoolchildren in the province to determine whether transmission could be occurring in the household instead of in the classroom.
